Log in
Sign Up. It's Free
Last Update: Oct, 21 2024
Overview
Dosage & Administration
Drug label
PubMed™ News
Patient education
FAQ
Trisenox
(arsenic trioxide)
Trisenox 12 MG in 6 ML Injection
BOXED WARNING
Get Patient Education Material
Dosage & Administration
Newly-diagnosed low-risk APL:
*
Induction:
Administer 0.15 mg/kg/day intravenously daily in combination with tretinoin until bone marrow remission. Do not exceed 60 days.
*
Consolidation:
Administer 0.15 mg/kg/day intravenously daily for 5 days per week during weeks 1-4 of each 8-week cycle for a total of 4 cycles in combination with tretinoin.
Relapsed or refractory APL:
*
Induction:
Administer 0.15 mg/kg/day intravenously daily until bone marrow remission. Do not exceed 60 days.
*
Consolidation:
Administer 0.15 mg/kg/day intravenously daily for 25 doses over a period of up to 5 weeks.
Trisenox Prescribing Information
Contact Medical Science Liaison
Report Adverse Event
Trisenox PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Trisenox Patient Education
To share resource; ask patient to:
1.
Pull out phone
2.
Open camera
3.
Scan QR code with camera
4.
Tap link
Trisenox FAQs
How is the dosage of Trisenox?
Trisenox is available in 1 dosages, including 2 mg/ml Injection 6 ml
What does Trisenox treat?
Trisenox treats Leukemia, Promyelocytic, Acute
How Is Trisenox Administered?
Trisenox is administered as a Injectable
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
